Priyanka Ganapathy

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Vascular Endothelial Growth Factor

Peritoneal Dialysis

Ejection Fraction

Patient Reported

Top Venues

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Priyanka Ganapathy, Vidya Devanatha Desikan Sheshadri, Rajesh Sarkar, Sumathi Jones, Krishnamoorthy Gunasekaran, Teka Obsa Feysia, Dhamodharan Umapathy, Saleem Basha
Vascular Endothelial Growth Factor Single Nucleotide Polymorphism +405 G/C (rs2010963) is associated with Levels, Infection Severity, and Amputation among South Indian Diabetic Foot Ulcer Patients. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Priyanka Ganapathy, Vidya Devanatha Desikan Sheshadri, Rajesh Sarkar, Sumathi Jones, Krishnamoorthy Gunasekaran, Teka Obsa Feysia, Dhamodharan Umapathy, Saleem Basha
Vascular Endothelial Growth Factor Single Nucleotide Polymorphism +405 G/C (rs2010963) is associated with Levels, Infection Severity, and Amputation among South Indian Diabetic Foot Ulcer Patients. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Priyanka Ganapathy, Vidya Devanatha Desikan Sheshadri, Rajesh Sarkar, Sumathi Jones, Krishnamoorthy Gunasekaran, Teka Obsa Feysia, Dhamodharan Umapathy, Saleem Basha
Vascular Endothelial Growth Factor Single Nucleotide Polymorphism +405 G/C (rs2010963) is associated with Levels, Infection Severity, and Amputation among South Indian Diabetic Foot Ulcer Patients. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Priyanka Ganapathy, Vidya Devanatha Desikan Sheshadri, Rajesh Sarkar, Sumathi Jones, Krishnamoorthy Gunasekaran, Teka Obsa Feysia, Dhamodharan Umapathy, Saleem Basha
Vascular Endothelial Growth Factor Single Nucleotide Polymorphism +405 G/C (rs2010963) is associated with Levels, Infection Severity, and Amputation among South Indian Diabetic Foot Ulcer Patients. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)